yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q47273306-35D8563A-9A2F-43CB-B240-0EDD124700B9
Q47273306-35D8563A-9A2F-43CB-B240-0EDD124700B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47273306-35D8563A-9A2F-43CB-B240-0EDD124700B9
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade.
P2860
Q47273306-35D8563A-9A2F-43CB-B240-0EDD124700B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47273306-35D8563A-9A2F-43CB-B240-0EDD124700B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69fdf5c240c058f906310faeab3f25c61f21791e
P2860
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.